Loading organizations...
§ Private Profile · St. Louis, MO, USA
SentiAR is a technology company.
SentiAR develops augmented reality technology that provides physicians with real-time, holographic visualization during complex interventional medical procedures. Its flagship product, the CommandEP system, projects interactive 3D images of patient anatomy, such as the inner heart surface, directly into the physician's field of view. This hands-free system integrates real-time data from catheters and electroanatomic mapping, enhancing precision and control without compromising sterility.
The company was co-founded by Dr. Jennifer Avari Silva, a pediatric cardiologist, and Dr. Jonathan Silva, an engineer, emerging from their collaborative work at Washington University Medical School in 2017. Their insight stemmed from the critical need to improve visual guidance and control in minimally-invasive procedures, where traditional imaging often falls short of the clarity offered by open surgeries. This interdisciplinary foundation propelled the development of their novel AR platform.
SentiAR's solutions are utilized by medical professionals, particularly those performing cardiac electrophysiology, who seek enhanced accuracy and efficiency in procedural execution and training. The company’s vision is to advance medical practice by providing an intuitive, comprehensive visual interface that simplifies complex data and ultimately leads to improved patient outcomes and more effective physician education.
SentiAR has raised $20.5M across 4 funding rounds.
SentiAR has raised $20.5M in total across 4 funding rounds.
SentiAR has raised $20.5M across 4 funding rounds. Most recently, it raised $8.5M Series B in April 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 12, 2023 | $8.5M Series B | R. Sean Churchill | Harmonix, MedVenture Partners, QRM Capital, TechWald Holding, Vcapital | Announced |
| Apr 1, 2021 | $5M Series A | — | Broadview Ventures, Cultivation Capital, Biogenerator, Keiretsu Forum, Neue Fund, QRM Capital, TechWald Holding, Vcapital | Announced |
| Feb 1, 2020 | $6M Seed | — | Broadview Ventures, Cultivation Capital | Announced |
| Aug 1, 2017 | $1M Seed | — | Broadview Ventures, Cultivation Capital | Announced |
SentiAR has raised $20.5M in total across 4 funding rounds.
SentiAR's investors include R. Sean Churchill, Harmonix, MedVenture Partners, QRM Capital, TechWald Holding, VCapital, Broadview Ventures, Cultivation Capital, BioGenerator, Keiretsu Forum, Neue Fund.
SentiAR is a technology company that develops an augmented reality (AR) platform called CommandEP, which provides real-time, interactive 3D holographic visualization of patient-specific cardiac anatomy during interventional procedures, particularly cardiac ablation for arrhythmias. This platform consolidates multiple imaging and catheter positioning data sources into a single intuitive interface, enabling electrophysiologists and cardiologists to perform procedures with enhanced accuracy, efficiency, and safety. By delivering hands-free control of 3D visuals via mixed reality hardware, SentiAR addresses the challenge of integrating complex spatial data in real time during minimally invasive surgeries, improving procedural outcomes and clinician experience[1][2][3][6].
SentiAR was spun out of Washington University in St. Louis in 2017, founded by Dr. Jennifer Avari Silva, a pediatric cardiologist and electrophysiologist, and Dr. Jonathan Silva, a biomedical engineering professor. The idea emerged from their research to improve visualization during cardiac procedures by creating a holographic platform that could display the heart’s anatomy and catheter positions in real time. Early traction included securing over $500,000 in grants to develop prototypes on Microsoft HoloLens and conducting in-human engineering trials. The company has since raised multiple funding rounds, including a $5.1 million Series A to accelerate development and commercialization of the CommandEP system[2][4][5].
SentiAR rides the growing trend of augmented and mixed reality applications in healthcare, particularly in minimally invasive surgeries where spatial understanding is critical. The timing is favorable due to advances in AR hardware, increasing demand for precision medicine, and regulatory clearances (FDA 510(k)) validating the technology’s safety and efficacy. SentiAR’s platform addresses a key market need by improving visualization in cardiac electrophysiology, a complex and high-stakes field, potentially setting a new standard for procedural guidance. Their technology also influences the broader ecosystem by demonstrating how AR can enhance clinical workflows, training, and patient communication in real time[1][3][4][9].
Looking ahead, SentiAR is positioned to expand its clinical applications beyond cardiac ablation to other interventional procedures, leveraging its scalable AR platform. Trends such as increasing adoption of mixed reality in healthcare, integration with advanced imaging modalities, and demand for improved procedural outcomes will shape its growth. Continued regulatory approvals and partnerships with medical device companies will likely accelerate market penetration. SentiAR’s influence may evolve from a niche cardiac tool to a broader surgical visualization platform, driving innovation in how clinicians interact with patient data during complex interventions and training.
This trajectory ties back to SentiAR’s founding mission: revolutionizing the operating room with real-time, patient-specific holographic visualization to improve safety, precision, and efficiency in interventional care.